(Q54722482)

English

The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

title

The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

1 reference

PINES A

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

publication date

1 October 1962

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

published in

British Journal of Diseases of the Chest

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

volume

56

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

page(s)

163-170

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

cites work

The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

Treatment of pulmonary tuberculosis by viomycin combined with oxytetracycline

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

Treatment of pulmonary tuberculosis with isoniazid and pyrazinamide: experience in 114 cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

1314 In pulmonary tuberculosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

The use of oxytetracycline in preventing or delaying isoniazid resistance in pulmonary tuberculosis; a report to the Research Committee of the Tuberculosis Society of Scotland.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0007-0971%2862%2980013-8

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0007-0971(62)80013-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

PubMed publication ID

13943667

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13943667

retrieved

3 June 2018

reference URL

http://europepmc.org/abstract/MED/13943667

(Q54722482)

The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)